Centre Hospitalier Regional Universitaire de Montpellier
USPTO PatentsView assignee record - 17 granted patents across 3 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Centre ranks #16,674 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 3 technology areas.
- #16,674
- of 49,997 US assignees by volume
- 14th percentile
- by Innovation Score (24.4/100)
- 9.3
- avg claims per patent
- -33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R16674 · Foreign Corporation #16,674 · 17 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 17 grants
- MID-PACK #16,674/49,997
- PHOTO-FINISH Cadent Therapeutics
- CPC-NARROW A61P · 3 areas
- INNOV-THIN 24.4/100
- CLAIMS-PAR 9.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Cadent Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Centre’s 24.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Centre
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Centre Hospitalier… · this assignee 24
Centre Hospitalier… · this assignee
24 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Centre's Innovation Score is 24.4/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Centre?
Each dot is one of Centre’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Centre’s own 9.3 claims/patent is at or below the 16.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Centre's grants concentrate
Centre Hospitalier Regional Universitaire de Montpellier is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (6 grants) versus a trough of 1 in 2016. By volume, Centre sits between Cadent Therapeutics, Inc. and Chi Hua Fitness Co., Ltd..
Centre's three-year grant acceleration
Centre Hospitalier Regional Universitaire de Montpellier shows 2 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Centre's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cadent Therapeuti…
Cadent Therapeutics, Inc.
17 patents
- Carver Scientific
Carver Scientific, Inc.
17 patents
- Catalyst Bioscien…
Catalyst Biosciences, Inc.
17 patents
- Cellular Dynamics…
Cellular Dynamics International, Inc.
17 patents
- Centro de Inmunol…
Centro de Inmunología Molecular
17 patents
- Cerus
Cerus Corporation
17 patents
- Chengdu Vistar Op…
Chengdu Vistar Optoelectronics Co., Ltd.
17 patents
- Chi Hua Fitness
Chi Hua Fitness Co., Ltd.
17 patents
- Centre Hospitalie… ◀
Centre Hospitalier Regional Universitaire de Montpellier
17 patents
What this shows Centre holds 17 patents at rank #16,691, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Centre
By rank, the assignees closest to #16,691 in granted patent volume.
- Cadent Therapeutics, Inc. #16,687 · 17 patents
- Carver Scientific, Inc. #16,688 · 17 patents
- Catalyst Biosciences, Inc. #16,689 · 17 patents
- Cellular Dynamics International, Inc. #16,690 · 17 patents
- Centro de Inmunología Molecular #16,692 · 17 patents
- Cerus Corporation #16,693 · 17 patents
- Chengdu Vistar Optoelectronics Co., Ltd. #16,694 · 17 patents
- Chi Hua Fitness Co., Ltd. #16,695 · 17 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Centre's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Centre's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 14th percentile higher than 14% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 5.9% |
| 2017 | 1 | 5.9% |
| 2018 | 6 | 35.3% |
| 2019 | 1 | 5.9% |
| 2020 | 2 | 11.8% |
| 2021 | 2 | 11.8% |
| 2022 | 2 | 11.8% |
| 2025partial year | 2 | 11.8% |
Which technologies does Centre Hospitalier Regional Universitaire de Montpellier patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Centre Hospitalier Regional Universitaire de Montpellier's patent record in context - here's where to go next.
- Centre Hospitalier Regional Universitaire de Montpellier's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #16,674 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Centre Hospitalier Regional Universitaire de Montpellier against Cadent Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 24.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.